江中药业2025年上半年净利润同比增长5.8%

Core Viewpoint - Jiangzhong Pharmaceutical announced a decline in operating revenue for the first half of 2025, while net profit showed an increase, indicating mixed financial performance [1] Financial Performance - The company achieved operating revenue of 2.141 billion yuan, a year-on-year decrease of 5.79% [1] - Net profit attributable to shareholders was 522 million yuan, reflecting a year-on-year increase of 5.8% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 482 million yuan, with a year-on-year growth of 2.31% [1]